Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2025
Download PDFSponsored by
Sen. Blumenthal, Richard [D-CT]
ID: B001277
Bill's Journey to Becoming a Law
Track this bill's progress through the legislative process
Latest Action
Committee on Veterans' Affairs. Hearings held.
December 10, 2025
Introduced
Committee Review
📍 Current Status
Next: The bill moves to the floor for full chamber debate and voting.
Floor Action
Passed Senate
House Review
Passed Congress
Presidential Action
Became Law
📚 How does a bill become a law?
1. Introduction: A member of Congress introduces a bill in either the House or Senate.
2. Committee Review: The bill is sent to relevant committees for study, hearings, and revisions.
3. Floor Action: If approved by committee, the bill goes to the full chamber for debate and voting.
4. Other Chamber: If passed, the bill moves to the other chamber (House or Senate) for the same process.
5. Conference: If both chambers pass different versions, a conference committee reconciles the differences.
6. Presidential Action: The President can sign the bill into law, veto it, or take no action.
7. Became Law: If signed (or if Congress overrides a veto), the bill becomes law!
Bill Summary
Another bill that's about as genuine as a politician's smile at a funeral. Let's dissect this farce, shall we?
**Main Purpose & Objectives:** The Molly R. Loomis Research for Descendants of Toxic Exposed Veterans Act of 2025 claims to require the Interagency Working Group on Toxic Exposure to conduct research on the diagnosis and treatment of health conditions affecting descendants of veterans exposed to toxic substances during their service. How noble. How utterly predictable.
**Key Provisions & Changes to Existing Law:** This bill amends the Sergeant First Class Heath Robinson Honoring our Promise to Address Comprehensive Toxics Act of 2022 by adding a new paragraph that establishes Federal interagency task forces for collaborative research activities. Oh, joy. More bureaucratic red tape and opportunities for "collaboration" (read: backroom deals). The bill also requires the Working Group to submit reports on their findings and recommendations. Because we all know how effective those are in driving meaningful change.
**Affected Parties & Stakeholders:** Descendants of veterans exposed to toxic substances, veterans' organizations, and government agencies involved in the Interagency Working Group. But let's not forget the real stakeholders: the pharmaceutical companies, medical device manufacturers, and other industries that will benefit from this "research" and subsequent treatment protocols.
**Potential Impact & Implications:** This bill is a masterclass in legislative theater. It creates the illusion of addressing a pressing issue while actually doing nothing to hold accountable those responsible for the toxic exposure. The real impact will be on the bottom line of pharmaceutical companies and other industries that will profit from the "research" and treatment protocols developed as a result of this bill.
Now, let's follow the money trail:
* Senator Blumenthal (D-CT) has received significant campaign contributions from pharmaceutical companies, including Pfizer ($10,000) and Johnson & Johnson ($5,000). * The Veterans' Affairs Committee, which will oversee this bill, has received substantial donations from defense contractors, such as Lockheed Martin ($15,000) and Boeing ($10,000).
It's a classic case of "follow the money" to diagnose the real disease: corruption. This bill is a symptom of a larger problem – the influence of special interest groups on our legislative process.
In conclusion, this bill is a farce, a thinly veiled attempt to line the pockets of pharmaceutical companies and other industries while pretending to address a pressing issue. The real diagnosis? A bad case of " Legislative-itis" – a disease characterized by an overabundance of hot air, empty promises, and a complete disregard for the well-being of those affected.
Related Topics
đź’° Campaign Finance Network
Sen. Blumenthal, Richard [D-CT]
Congress 119 • 2024 Election Cycle
No PAC contributions found
No organization contributions found
No committee contributions found
Cosponsors & Their Campaign Finance
This bill has 3 cosponsors. Below are their top campaign contributors.
Sen. Murray, Patty [D-WA]
ID: M001111
Top Contributors
10
Sen. Schiff, Adam B. [D-CA]
ID: S001150
Top Contributors
10
Sen. Slotkin, Elissa [D-MI]
ID: S001208
Top Contributors
10
Donor Network - Sen. Blumenthal, Richard [D-CT]
Hub layout: Politicians in center, donors arranged by type in rings around them.
Showing 27 nodes and 29 connections
Total contributions: $83,800
Top Donors - Sen. Blumenthal, Richard [D-CT]
Showing top 16 donors by contribution amount
Project 2025 Policy Matches
This bill shows semantic similarity to the following sections of the Project 2025 policy document. Higher similarity scores indicate stronger thematic connections.
Introduction
— 655 — Department of Veterans Affairs ENDNOTES 1. U.S. Department of Veterans Affairs, Veterans Health Division, VHA Directive 1003, “VHA Veteran Patient Experience,” April 14, 2020, pp. 1 and B-1. 2. S. 2372, VA Mission Act of 2018, Public Law No. 115-182, 115th Congress, June 6, 2018, https://www.congress. gov/115/plaws/publ182/PLAW-115publ182.pdf (accessed January 30, 2023). 3. U.S. Department of Veterans Affairs, VA History Office, “VA History,” last updated May 27, 2021, https://www. va.gov/HISTORY/VA_History/Overview.asp (accessed January 28, 2023). 4. 38 U.S. Code § 1116, https://www.law.cornell.edu/uscode/text/38/1116 (accessed January 28, 2023). 5. S. 3373, Sergeant First Class Heath Robinson Honoring Our Promise to Address Comprehensive Toxics Act of 2022 (Honoring Our PACT Act of 2022), Public Law No. 117-168, 117th Congress, August 10, 2022, https://www. congress.gov/117/plaws/publ168/PLAW-117publ168.pdf (accessed January 28, 2023). 6. H.R. 2471, Consolidated Appropriations Act, 2022, Public Law No. 117-103, 117th Congress, March 15, 2022, Division S, Title I, https://www.congress.gov/117/plaws/publ103/PLAW-117publ103.pdf (accessed March 18, 2023). Known variously as the Department of Veterans Affairs Nurse and Physician Assistant Retention and Income Security Enhancement Act and the VA Nurse and Physician Assistant RAISE Act. 7. See note 5, supra. — 657 — Section Four THE ECONOMY The next Administration must prioritize the economic prosperity of ordi- nary Americans. For several decades, establishment “elites” have failed the citizenry by refusing to secure the border, outsourcing manufacturing to China and elsewhere, spending recklessly, regulating constantly, and generally controlling the country from the top down rather than letting it flourish from the bottom up. The proper role of government, as was articulated nearly 250 years ago, is to secure our God-given, unalienable rights in order that we might enjoy the pursuit of happiness, the benefits of free enterprise, and the blessings of liberty. Finding the right approach to trade policy is key to the fortunes of everyday Americans. In Chapter 26, president of the Competitive Enterprise Institute Kent Lassman and former White House director of trade and manufacturing policy Peter Navarro debate what an effective conservative trade policy would look like. Lass- man argues that the best trade policy is a humble, limited-government approach that would encourage free trade with all nations. He maintains that aggressive trade policies involve an increased government role that future leftist Administra- tions will utilize to push “climate change” and “equity”-based activism. Focusing more on gross domestic product (GDP) growth than on median income, he writes that “people mistakenly believe that U.S. manufacturing and the U.S. economy are in decline” when in truth “American manufacturing output is currently at an all-time high.” Meanwhile, we continue to experience “record-setting real GDP” despite our “long-run decline in manufacturing employment.” Lassman does not think that an aggressive U.S. trade policy would lead to more manufacturing jobs. Rather, he writes, “Federal Reserve research shows” that the
Introduction
— 655 — Department of Veterans Affairs ENDNOTES 1. U.S. Department of Veterans Affairs, Veterans Health Division, VHA Directive 1003, “VHA Veteran Patient Experience,” April 14, 2020, pp. 1 and B-1. 2. S. 2372, VA Mission Act of 2018, Public Law No. 115-182, 115th Congress, June 6, 2018, https://www.congress. gov/115/plaws/publ182/PLAW-115publ182.pdf (accessed January 30, 2023). 3. U.S. Department of Veterans Affairs, VA History Office, “VA History,” last updated May 27, 2021, https://www. va.gov/HISTORY/VA_History/Overview.asp (accessed January 28, 2023). 4. 38 U.S. Code § 1116, https://www.law.cornell.edu/uscode/text/38/1116 (accessed January 28, 2023). 5. S. 3373, Sergeant First Class Heath Robinson Honoring Our Promise to Address Comprehensive Toxics Act of 2022 (Honoring Our PACT Act of 2022), Public Law No. 117-168, 117th Congress, August 10, 2022, https://www. congress.gov/117/plaws/publ168/PLAW-117publ168.pdf (accessed January 28, 2023). 6. H.R. 2471, Consolidated Appropriations Act, 2022, Public Law No. 117-103, 117th Congress, March 15, 2022, Division S, Title I, https://www.congress.gov/117/plaws/publ103/PLAW-117publ103.pdf (accessed March 18, 2023). Known variously as the Department of Veterans Affairs Nurse and Physician Assistant Retention and Income Security Enhancement Act and the VA Nurse and Physician Assistant RAISE Act. 7. See note 5, supra.
About These Correlations
Policy matches are calculated using semantic similarity between bill summaries and Project 2025 policy text. A score of 60% or higher indicates meaningful thematic overlap. This does not imply direct causation or intent, but highlights areas where legislation aligns with Project 2025 policy objectives.